Professor, Medical Geneticist and Clinician-Scientist
CHU Sainte-Justine, Université de Montréal (Canada)
Montreal, Quebec, Canada
Dr Laberge is a Medical Geneticist and Head of the Division of Medical Genetics at CHU Ste-Justine, and Clinical Full Professor in the Department of Pediatrics and in the Department of Social and Preventive Medicine at the School of Public Health at the University of Montreal. She obtained a B.Sc. in Biochemistry and MD at Université de Montréal. Dr Laberge completed a residency in Medical Genetics at Université de Montréal. She then completed an MPH in Public Health Genetics, on the factors predicting the success of carrier screening programs, and a PhD in Public Health Genetics, on the clinical utility of genetic tests and the role of guidelines in defining standard of care, both at the University of Washington. Dr Laberge was president of the Quebec Medical Geneticists Association for 5 years and is currently Chair of the Quebec Advisory Committee on Newborn Screening, of the Quebec Molecular Diagnosis Network Incidental Findings Working Group and of the newly formed Quebec Central Ethics Committee on Medically Assisted Reproduction. Dr Laberge’s current research focuses on the use of genetic tests in practice and how genetic information influences patient management and individual decision-making. Her current research includes an assessment of carrier screening programs in Quebec, the ethical and social issues around the expansion of NIPT in prenatal care in Canada and a pragmatic evaluation of the clinical utility and stakeholder perspectives of exome and genome sequencing in pediatric care.
Disclosure information not submitted.
31- How does the severity of a genetic condition affect the utility of knowing about it?
Tuesday, June 11, 2024
5:00 PM – 7:00 PM ET